Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolated in serial cultures from the respiratory tract of children with cystic fibrosis

Pediatric Infectious Disease Journal

Volumn 33, Issue 6, 2014, Pages 549-553

  Al Zubeidi, Duha ^a,b   Hogan, Patrick G ^a   Boyle, Mary ^a   Burnham, Carey Ann D ^a   Fritz, Stephanie A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

cystic fibrosis; Methicillin resistant Staphyloccocus aureus; molecular epidemiology

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CHILD; CHILDHOOD DISEASE; CHROMOSOME; CORRELATIONAL STUDY; CYSTIC FIBROSIS; FEMALE; GENETIC VARIABILITY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR EPIDEMIOLOGY; NEWBORN; PATIENT IDENTIFICATION; POLYMERASE CHAIN REACTION; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; DRUG EFFECTS; GENETICS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PRESCHOOL CHILD; SPUTUM; STAPHYLOCOCCAL INFECTIONS;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; RETROSPECTIVE STUDIES; SPUTUM; STAPHYLOCOCCAL INFECTIONS;

EID: 84901480797     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000204     Document Type: Article

References (39)

1. Goss CH Muhlebach MS. Review: Staphylococcus aureus and MRSA in cystic fibrosis. J Cyst Fibros. 2011;10:298-306.
2. Armstrong DS Grimwood K Carlin JB et al. Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med. 1997;156(4 pt 1):1197-1204.
3. Cystic Fibrosis Foundation Patient Registry. 2011 Annual Data Report. Bethesda MD: 2012 Cystic Fibrosis Foundation Available at: http://www.cff.org/ UploadedFiles/research/ClinicalResearch/2011-Patient-Registry.pdf. Accessed January 23 2014.
4. Otter JA French GL. Community-associated meticillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated infection. J Hosp Infect. 2011;79:189-193.
5. Boye K Bartels MD Andersen IS et al. A new multiplex PCR for easy screening of methicillin-resistant Staphylococcus aureus SCCmec types I-V. Clin Microbiol Infect. 2007;13:725-727. (Pubitemid 46909351)
6. Gostev VV Sidorenko SV. [Staphylococcal cassette chromosome mec evolution and genetic lines of methicillin resistant Staphylococcus aureus]. Antibiot Khimioter. 2012;57:38-46.
7. Glikman D Siegel JD David MZ et al. Complex molecular epidemiology of methicillin-resistant Staphylococcus aureus isolates from children with cystic fibrosis in the era of epidemic community-associated methicillin-resistant S aureus. Chest. 2008;1 33:1381-1387. (Pubitemid 351892994)
8. Elizur A Orscheln RC Ferkol TW et al. Panton-Valentine Leukocidin-positive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis. Chest. 2007;131:1718-1725. (Pubitemid 46981625)
9. Kidd TJ Grimwood K Ramsay KA et al. Comparison of three molecular techniques for typing Pseudomonas aeruginosa isolates in sputum samples from patients with cystic fibrosis. J Cli n Microbiol. 2011;49:263-268.
10. Silbert S Barth AL Sader HS. Heterogeneity of Pseudomonas aeruginosa in Brazilian cystic fibrosis patients. J Clin Microbiol. 2001;39:3976-3981. (Pubitemid 33029770)
11. Boukadida J De Montalembert M Lenoir G et al. Molecular epidemiology of chronic pulmonary colonisation by Pseudomonas aeruginosa in cystic fibrosis. J Med Microbiol. 1993;38:29-33. (Pubitemid 23025178)
12. Solís A Brown D Hughes J et al. Methicillin-resistant Staphylococcus aureus in children with cystic fibrosis: an eradication protocol. Pediatr Pulmonol. 2003;36:189-195. (Pubitemid 37055965)
13. Va nderhelst E De Wachter E Willekens J et al. Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of 11 patients. J Cyst Fibros. 2013;12:662-666.
14. Vanderhelst E De Meirleir L Verbanck S et al. Prevalence and impact on FEV(1) decline of chronic methicillin-resistant Staphylococc us aureus (MRSA) colonization in patients with cystic fibrosis. A single-center case control study of 165 patients. J Cyst Fibros. 2012;11:2-7.
15. Miall LS McGinley NT Brownlee KG et al. Methicillin resistant Staphylococcus aureus (MRSA) infection in cystic fibrosis. Arch Dis Child. 2001;84:160-162. (Pubitemid 32150334)
16. Dasenbrook EC Checkley W Merlo CA et al. Association between respiratory tract me thicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. JAMA. 2010;303:2386-2392.
17. Taccetti G Neri AS Festini F et al. Methicillin resistant Staphylococcus aureus in cystic fibrosis. Pediatr Pulmonol. 2008;43:309; author reply 310. (Pubitemid 351374466)
18. Ren CL Morgan WJ Konstan MW et al.; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Presence o f methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function. Pediatr Pulmonol. 2007;42:513-518. (Pubitemid 46870382)
19. Al-Zubeidi D Burnham CD Hoga n GP et al. Molecular Epidemiology of Recurrent Cutaneous Methicillin-Resistant Staphylococcus aureus Infections in Children. JPIDS. [published online ahead of print July 30 2013]. doi: 10.1093/jpids/pit046.
20. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement; M100-S23. Clinical and Laboratory Standards Institute Wayne PA January 2013 Update.
21. Fritz SA Hogan PG Camins BC et al. Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with communityonset skin and soft tissue infections. Antimicrob Agents Chemother. 2013;57:559-568.
22. El Feghaly RE Stamm JE Fritz SA et al. Presence of the bla(Z) beta-lactamase gene in isolates of Staphylococcus aureus that appear penicillin susceptible by conventional phenotypic methods . Diagn Microbiol Infect Dis. 2012;74:388-393.
23. Goodrich JS Sutton-Shields TN Kerr A et al. Prevalence of community-associated methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis. J Clin Microbiol. 2009;47:1231-1233.
24. Stone A Quittell L Zhou J et al. Staphylococcus aureus nasal colonization among pediatric cystic fibrosis patients and their household contacts. Pediatr Infect Dis J. 2009;28:895-899.
25. Popovich KJ Weinstein RA Hota B. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional noso comial MRSA strains Clin Infect Dis. 2008;46:787-794. (Pubitemid 351417176)
26. Liu C Graber CJ Karr M et al. A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco 2004-2005. Clin Infect Dis. 2008;46:1637-1646. (Pubitemid 351706759)
27. Saiman L O'Keefe M Graham PL 3rd et al. Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin Infect Dis. 2003;37:1313-1319. (Pubitemid 37433626)
28. Centers for Disease Control and Prevention. Community-associated methicillin-resistant Staphylococcus aureus infection among healthy newborns-Chicago and Los Angeles County 2004. MMWR Morb Mortal Wkly Rep. 2006; 55:329-332.
29. Hultén KG Kaplan SL Lamberth LB et al. Hospital-acquired Staphylococcus aureus infections at Texas Children's Hospital 2001-2007. Infect Control Hosp Epidemiol. 2010;31:183-190.
30. Gonzalez BE Rueda AM Shelburne SA 3rd et al. Community-associated strains of methicillin-resistant Staphylococccus aureus as the cause of healthcare-associated infection. Infect Control Ho sp Epidemiol. 2006;27:1051-1056. (Pubitemid 44670980)
31. Healy CM Hulten KG Palazzi DL et al. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin Infect Dis. 2004;39:1460-1466. (Pubitemid 39518209)
32. Cocchi P Cariani L Favari F et al Molecular epidemiology of meticillin-resistant Staphylococcus aureus in Italian cystic fibrosis patients: a national overview J Cyst Fibros 2011 10 407-411.
33. Cramer N Wiehlmann L Ciofu O et al. Molecular epidemiology of chronic Pseudomonas aeruginosa airway infections in cystic fibrosis. PLoS One. 2012;7:e50731.
34. Saiman L Siegel J; Cystic Fibrosis Foundation. Infection control recommendations for patients with cystic fibrosis: microbiology important pathogens and infection control practices to prevent pati ent-to-patient transmission. Infect Control Hosp Epidemiol. 2003;24(5 suppl):S6-52.
35. Goerke C Wolz C. Adaptation of Staphylococcus aureus to the cystic fibrosis lung. Int J Med Microbiol. 2010;300:520-525.
36. Mitchell G Grondin G Bilodeau G et al. Infection of polarized airway epithelial cells by normal and small-colony variant strains of Staphylococcus aureus is increased in cells with abnorm al cystic fibrosis transmembrane conductance regulator function and is influenced by NF-B. Infect Immun. 2011;79:3541-3551.
37. Yagci S Hascelik G Dogru D et al. Prevalence and genetic diver sity of Staphylococcus aureus small-colony variants in cystic fibrosis patients. Clin Microbiol Infect. 2013;19:77-84.
38. Dasenbrook EC. Update on methicillin-resistant Staphylococcus aureus in cystic fibrosis. Curr Opin Pulm Med. 2011;17:437-441.
39. Wolter DJ Emerson JC McNamara S et al. Staphylococcus aureus small-colony variants are independently associated with worse lung disease in child ren with cystic fibrosis. Clin Infect Dis. 2013;57:384-391.